This idea aligns with a study from Milenkovic and colleagues (103), where they examined the two most frequently occurring missense mutations of TSPO (A147T, R162H), which were linked to reduced function and possible neurological disorders, and found that they decreased the half-life of the protein by 25%. Here, TSPO is linked to nervous system disorder.